isradipine has been researched along with Coronary Artery Disease in 3 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
Excerpt | Relevance | Reference |
---|---|---|
"9 years), at the dosage of 5 mg once a day." | 3.78 | [Metabolic tolerance of isradipine. Evaluation after three months of therapy]. ( Bernardini, A; Capone, A; Panuccio, D; Trabatti, MR, 1995) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Panuccio, D | 1 |
Trabatti, MR | 1 |
Bernardini, A | 1 |
Capone, A | 1 |
Borhani, NO | 1 |
Brugger, SB | 1 |
Byington, RP | 1 |
Hof, RP | 1 |
Hof, A | 1 |
Takiguchi, Y | 1 |
1 review available for isradipine and Coronary Artery Disease
Article | Year |
---|---|
[Metabolic tolerance of isradipine. Evaluation after three months of therapy].
Topics: Aged; Blood Pressure; Calcium Channel Blockers; Cerebrovascular Disorders; Coronary Artery Disease; | 1995 |
2 trials available for isradipine and Coronary Artery Disease
Article | Year |
---|---|
[Metabolic tolerance of isradipine. Evaluation after three months of therapy].
Topics: Aged; Blood Pressure; Calcium Channel Blockers; Cerebrovascular Disorders; Coronary Artery Disease; | 1995 |
Multicenter study with isradipine and diuretics against atherosclerosis. US MIDAS Research Group.
Topics: Arteriosclerosis; Calcium Channel Blockers; Carotid Artery Diseases; Coronary Artery Disease; Diuret | 1990 |
1 other study available for isradipine and Coronary Artery Disease
Article | Year |
---|---|
Comparative hemodynamic studies of isradipine and dihydralazine in atherosclerotic and normal rabbits.
Topics: Animals; Arteriosclerosis; Calcium Channel Blockers; Coronary Artery Disease; Dihydralazine; Electro | 1990 |